Related Experiment Video

Updated: Oct 17, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Do TNF-alpha-insensitive cancer cells escape alpha-tubulin nitrotyrosination?

H T Idriss1

  • 1School of Biomedical Sciences, University of St. Andrews, North Haugh, Fife, KY16 9ST, Scotland. hi@st-and.ac.uk

Nitric Oxide : Biology and Chemistry
|March 29, 2000
PubMed

Insights

Tumor necrosis factor-alpha (TNF-alpha) may kill cancer cells via nitric oxide-mediated alpha-tubulin nitrotyrosination. Resistance to TNF-alpha might stem from reduced tubulin tyrosine ligase levels, impacting alpha-tubulin tyrosination.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Tumor necrosis factor-alpha (TNF-alpha) exhibits anti-cancer properties, but tumor resistance limits its efficacy.
  • Understanding mechanisms of TNF-alpha-induced cytotoxicity and resistance is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To hypothesize that nitric oxide-mediated alpha-tubulin posttranslational nitrotyrosination is a key mechanism for TNF-alpha's cytotoxic effects.
  • To propose that suppressed tubulin tyrosine ligase levels contribute to TNF-alpha resistance in tumors.

Main Methods:

  • Hypothetical review and synthesis of existing literature on TNF-alpha, nitric oxide, and tubulin modifications.
  • Analysis of the proposed molecular pathways involving alpha-tubulin nitrotyrosination and tyrosination.

Main Results:

  • Nitric oxide-mediated alpha-tubulin nitrotyrosination is proposed as a significant cytotoxic pathway for TNF-alpha.
  • Suppressed tubulin tyrosine ligase activity is hypothesized to underlie resistance to TNF-alpha by preventing alpha-tubulin tyrosination.

Conclusions:

  • The proposed mechanism highlights a novel pathway for TNF-alpha-induced cancer cell death.
  • Targeting tubulin tyrosine ligase or related pathways may overcome TNF-alpha resistance in certain cancers.

More Related Videos

Isolation and Characterization of Neutrophils with Anti-Tumor Properties10:15

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Published on: June 19, 2015

Time-Lapse Imaging of Antibody-Driven Macrophage Phagocytosis of Green Fluorescence Protein–Labeled Triple-Negative Breast Cancer Cells09:32

Time-Lapse Imaging of Antibody-Driven Macrophage Phagocytosis of Green Fluorescence Protein–Labeled Triple-Negative Breast Cancer Cells

Published on: August 14, 2026

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...